In future studies, the role of PTPN22 in the process of autoimmune tolerance breaking during the initial phase of autoimmune disease as well as the negative immunoregulatory effect of the CTLA-4 gene should be determined to reveal the common mechanisms of these diseases. The gene discussed is CTLA4; the disease is autoimmune disease.